価格表

在庫・価格 : 2026年04月12日 18時52分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
BAFF, Human, Recombinant <BLyS> <TNFSF13B>
データシート
2149-BF-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg 本製品は取扱中止になりました 追加

在庫・価格 : 2026年04月12日 18時52分 現在

BAFF, Human, Recombinant <BLyS> <TNFSF13B>

  • 商品コード:2149-BF-010
  • メーカー:RSD
  • 包装:10μg
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Day ES et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 2005 Feb;44(6):1919-31
Day ES et al
2005/01/01
Species: Human, Application: Binding Assay, Sample type: recombinant BAFFR, recombinant BCMA PubMed
2 Lu J et al. Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2006 Apr;103(15):5688-93
Lu J et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Kato A et al. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J. Immunol. 2006 Nov;177(10):7164-72
Kato A et al
2006/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
4 Nedvetzki S et al. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007 May;109(9):3776-85
Nedvetzki S et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
5 Ettinger R et al. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 2007 Mar;178(5):2872-82
Ettinger R et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
6 Darce JR et al. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 2007 May;178(9):5612-22
Darce JR et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
7 Kaur K et al. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007 Oct;110(8):2948-54
Kaur K et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
8 Neri P et al. Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model. Clin. Cancer Res. 2007 Oct;13(19):5903-9
Neri P et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
9 Moreau AS et al. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia. Br. J. Haematol. 2008 Sep;142(5):775-85
Moreau AS et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
10 Hemingway F et al. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011 Apr;48(4):938-44
Hemingway F et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Bloom D et al. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am. J. Transplant. 2009 Aug;9(8):1835-45
Bloom D et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Zhu J et al. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells. J. Exp. Clin. Cancer Res. 2012;31:31
Zhu J et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 Chiang EY et al. In vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-disease. PLoS ONE 2012;7(3):e33106
Chiang EY et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Negro R et al. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. Blood 2012 Jun;119(26):6278-87
Negro R et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
15 Sahaf B et al. H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease. Proc. Natl. Acad. Sci. U.S.A. 2013 Feb;110(8):3005-10
Sahaf B et al
2013/01/01
Application: Bioassay, Sample Type: Whole Blood PubMed
16 Deknuydt F et al. Diversion of the host humoral response: a novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles. J. Leukoc. Biol. 2014 Jun;95(6):983-91
Deknuydt F et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
17 Caro-Maldonado A et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 2014 Apr;192(8):3626-36
Caro-Maldonado A et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
18 Chinen Y et al. Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma. Cancer Res. 2014 Dec;74(24):7418-29
Chinen Y et al
2014/01/01
Application: Bioassay, Sample Type: whole cells PubMed
19 Mamara A et al. TACI expression and signaling in chronic lymphocytic leukemia. J Immunol Res 2015;2015:478753
Mamara A et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Day ES et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 2005 Feb;44(6):1919-31
    Day ES et al
    2005/01/01
  • 備考:
    Species: Human, Application: Binding Assay, Sample type: recombinant BAFFR, recombinant BCMA
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Lu J et al. Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2006 Apr;103(15):5688-93
    Lu J et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kato A et al. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J. Immunol. 2006 Nov;177(10):7164-72
    Kato A et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nedvetzki S et al. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007 May;109(9):3776-85
    Nedvetzki S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ettinger R et al. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 2007 Mar;178(5):2872-82
    Ettinger R et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Darce JR et al. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 2007 May;178(9):5612-22
    Darce JR et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kaur K et al. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007 Oct;110(8):2948-54
    Kaur K et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Neri P et al. Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model. Clin. Cancer Res. 2007 Oct;13(19):5903-9
    Neri P et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Moreau AS et al. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia. Br. J. Haematol. 2008 Sep;142(5):775-85
    Moreau AS et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Hemingway F et al. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011 Apr;48(4):938-44
    Hemingway F et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Bloom D et al. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am. J. Transplant. 2009 Aug;9(8):1835-45
    Bloom D et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zhu J et al. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells. J. Exp. Clin. Cancer Res. 2012;31:31
    Zhu J et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Chiang EY et al. In vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-disease. PLoS ONE 2012;7(3):e33106
    Chiang EY et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Negro R et al. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. Blood 2012 Jun;119(26):6278-87
    Negro R et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Sahaf B et al. H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease. Proc. Natl. Acad. Sci. U.S.A. 2013 Feb;110(8):3005-10
    Sahaf B et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Blood
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Deknuydt F et al. Diversion of the host humoral response: a novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles. J. Leukoc. Biol. 2014 Jun;95(6):983-91
    Deknuydt F et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Caro-Maldonado A et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 2014 Apr;192(8):3626-36
    Caro-Maldonado A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Chinen Y et al. Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma. Cancer Res. 2014 Dec;74(24):7418-29
    Chinen Y et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Mamara A et al. TACI expression and signaling in chronic lymphocytic leukemia. J Immunol Res 2015;2015:478753
    Mamara A et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed